Senti Biosciences Inc (SNTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 56,034 | 985 | 1,097 | N/A |
| Receivables | 483 | N/A | N/A | N/A |
| Other current assets | 0 | 0 | 0 | 374 |
| TOTAL | $60,193 | $1,658 | $1,884 | $374 |
| Non-Current Assets | ||||
| PPE Net | 12,368 | N/A | N/A | N/A |
| Investments And Advances | 0 | 230,004 | 230,001 | 0 |
| Other Non-Current Assets | 24,141 | 0 | 0 | 0 |
| TOTAL | $36,509 | $230,004 | $230,001 | $N/A |
| Total Assets | $96,702 | $231,662 | $231,885 | $374 |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 626 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 5,187 | 0 | 5 | 12 |
| Accrued Expenses | 5,331 | 33 | 2 | 338 |
| TOTAL | $14,543 | $129 | $61 | $350 |
| Non-Current Liabilities | ||||
| Deferred Revenues | 1,656 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 193,440 | 230,000 | 230,000 | 0 |
| TOTAL | $193,616 | $238,050 | $238,050 | $N/A |
| Total Liabilities | $208,159 | $238,179 | $238,111 | $350 |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 2,947 | 2,947 | 2,947 | 2,947 |
| Common Shares | N/A | 1 | 1 | 1 |
| Retained earnings | -115,076 | -6,518 | -6,226 | -1 |
| TOTAL | $-111,457 | $-6,517 | $-6,226 | $24 |
| Total Liabilities And Equity | $96,702 | $231,661 | $231,885 | $374 |